Skip to content

Homeopathic medicines in sinus complaints

Individualized homeopathic medicines in chronic rhinosinusitis: Randomized, double-blind, placebo-controlled, feasibility trial

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031476
Enrollment
40
Registered
2021-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J329- Chronic sinusitis, unspecified

Interventions

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cases suffering from chronic rhinosinusitis for 12 weeks or more (2020 ICD-10-CM diagnosis code J32.9), but had not taken any treatment since last 2 weeks, and fulfilled the diagnostic criteria of AAO-HNS 2. Age 18-65 years 3. Patients of either sex 4. Patients who are literate and capable of filling the questionnaire and providing written informed consent

Exclusion criteria

Exclusion criteria: 1. Cases suffering from uncontrolled systemic illness or life-threatening infections 2. Cases suffering from complications of CRS 3. Cases insisting for or in need of surgical interventions 4. Cases already undergoing homeopathic treatment for any chronic disease 5. Substance abuse and/or dependence 6. Pregnant, puerperial or lactating women 7. Patients with psychiatric diseases 8. Self-reported immune-compromised states

Design outcomes

Primary

MeasureTime frame
Sino-nasal Outcome Test-22 (SNOT-22) questionnaire scoreTimepoint: At baseline and after 2 months

Secondary

MeasureTime frame
EQ-5D-5L questionnaire and VAS scoresTimepoint: At baseline and after 2 months

Countries

India

Contacts

Public ContactSamiul Ansary

D. N. De Homoeopathic Medical College and Hospital

shyamalmukhergee@gmail.com9831113383

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026